Saving the Lives of People with Blood Cancer
by
An Interview with Diana Hernandez, Anthony Nolan Research Institute’s Head of the Immunotherapy Group Tell us a bit about yourself and your background: My name is Diana Hernandez, and I have recently been appointed Head of the Immunotherapy Group at the Anthony Nolan Research Institute. Prior to my appointment here, I was Principal Scientist…
by
49-year-old Deborah lives in Drayton, North Worcestershire with her partner. She has two children and is the Public Health Director for Dudley. Deborah was diagnosed with acute myeloid leukaemia in January 2016. She was treated with chemotherapy and had a stem cell transplant in June 2016 and is currently participating in a clinical trial. …
by
An exciting new therapy for people with blood cancer has been approved for use in the USA. It involves collecting a patient’s own immune cells, modifying them to target cancer cells more efficiently and then injecting them back into the patient. The treatment, called Kymriah and produced by drug company Novartis, is one of many…
by
James Robinson, Senior Bioinfomatics Scientist at the Anthony Nolan Research Institute, is part of the team that runs the HLA database – keeping track of the thousands of genetic variations that we come across when typing donors and patients.
Here, he tells us why that work is important and explains his latest research findings.
by
After Ronnie Manders was born with a rare form of childhood leukaemia, his family began rallying – both to add more donors to the Anthony Nolan register, and to raise lifesaving money in support of our research. This is the story of an amazing family – Ronnie’s family.
by
Exciting news from the world of research – a new test has been developed which uses biomarkers to help identify which patients have a higher risk of developing complications post-transplant.
In today’s blog, we give you the facts.
